FL-VIRGIN-VOYAGES
Virgin Voyages, the new lifestyle brand set to disrupt the travel industry, today announced its exclusive on-demand champagne delivery service, Shake for Champagne™ . Continuing to create the most irresistible experiences at sea, Virgin Voyages is enabling Sailors to request champagne, anywhere on board Scarlet Lady, with a simple shake of their phone.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191009005133/en/
Those looking to take indulgence to the next level can also treat themselves in the newly revealed luxurious champagne lounge and caviar bar, Sip .
“It is never too early for champagne and there is always something to toast to while aboard Scarlet Lady. We want our Sailors to enjoy a glamorous holiday and what better way to feel like a RockStar than a sip of bubbly whenever and wherever you want it,” said Tom Mcalpin, president and CEO of Virgin Voyages.
SHAKE FOR CHAMPAGNE™
Virgin Voyages is giving its Sailors one more reason to celebrate all of life’s moments with its on-demand delivery service, Shake for Champagne™. When the Virgin Voyages Sailor App is shaken, a secret Virgin Voyages Champagne button is revealed and, with just one press, a bottle of Möet & Chandon Impérial will be delivered to the Sailor.
“There’s nothing more luxurious than having champagne at your beck and call or even a shake. We are committed to creating the world’s most irresistible travel brand, so we thought long and hard about how to help our Sailors effortlessly get a sip of bubbly during their voyage, and presto Shake for Champagne™ was conjured up!” said Nathan Rosenberg, CMO for Virgin Voyages.
Delivered in an eye-catching, gleaming Virgin red champagne bucket, which is sure to make everyone around envious, the service includes a 750ml bottle of Möet & Chandon Impérial with two glasses. Möet & Chandon Impérial is a blend of over 200 crus, mingling the full body of pinot noir with the suppleness of Meunier and the finesse of chardonnay – the perfect pairing for a day or evening sailing in the warm Caribbean sea.
SIP
Sip is a decadent lounge designed to be enjoyed with a chilled glass of bubbles. Featuring a diverse curation of champagne labels, including Moët & Chandon – Virgin Voyages’ featured champagne house. Sailors can opt for a glass of bubbles priced from $9 or splash out on a $1,000 vintage bottle. In a nod to Virgin’s quintessential British heritage and eccentricity, Sip will offer a signature afternoon high tea, which will delight the eyes as well as the taste buds, while celebrating oceanic elements.
Designed by the Virgin Voyages design team, with spatial design by HKS Hospitality Interiors, the lounge was inspired by the glamour and effervescence of champagne. Featuring a long marble bar with rose-gold inlay, Sip encourages Sailors to indulge in one of the most luxurious pairings of them all, champagne and caviar. Gold and rose-pink hues echo the color of the champagnes that will be served, and are beautifully offset by deep watery blues and carrara white marble bars and tables. The deep ocean blue banquette wall and carpet that wraps through the space, will create a chance to revel or relax at all times of day as the ship sails through the ocean’s blue waves.
LIMITED-TIME BOOKING OFFER
Sailors can toast to Virgin Voyages’ inaugural season now through November 30, as those who book April or May sailings will receive a complimentary special Virgin Voyages limited-edition bottle of Möet & Chandon Impérial in their cabin upon their arrival. In addition, Sailors who book now can snag their voyage with half off their deposit. Future Sailors and First Mates are invited to check out Virgin Voyages by visiting www.virginvoyages.com .
ABOUT VIRGIN VOYAGES
Virgin Voyages is a global lifestyle brand committed to creating the world’s most irresistible holiday. With operations in the US, UK, and Europe, Virgin Voyages currently has four ships on order with master shipbuilder Fincantieri.
With its inaugural season scheduled for 2020, Virgin Voyages’ first ship Scarlet Lady was designed to reflect a yacht’s sleek luxury. Featuring spaces designed by some of the top names in contemporary design, Scarlet Lady will be Adult-by-Design, a sanctuary at sea for the 18+ traveler.
A dose of ‘Vitamin Sea’ will be naturally intertwined across the entire ship, with well-being activated through a mix of high-energy moments coupled with relaxation and rejuvenation. The Scarlet Lady will also feature alluring entertainment and 20+ world-class intimate eateries on board. Putting a twist on luxury, which the company refers to as Rebellious Luxe, Virgin Voyages will offer incredible value for its Sailors with all restaurants, group fitness classes, soft drinks, gratuities, WiFi and many more Virgin surprises included within the voyage fare.
Scarlet Lady will sail from Miami to the Caribbean in 2020, hosting more than 2,770 sailors and 1,150 amazing crew from around the world. Keep watch on virginvoyages.com for more updates.
Follow Virgin Voyages:
Instagram: @virginvoyages
Facebook: @virginvoyages
Twitter: @virginvoyages
LinkedIn: Virgin Voyages
YouTube: Virgin Voyages
View source version on businesswire.com: https://www.businesswire.com/news/home/20191009005133/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment2.12.2025 14:30:00 CET | Press release
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development and clinical validation of innovative treatments of pulmonary diseases by inhalation, and Merxin Ltd, a designer and supplier of inhaler devices, have entered a strategic collaboration to develop a pioneering inhaled genetic therapy targeting lung cancer. The partnership draws upon CorriXR’s proprietary CRISPR-based gene editing platform targeting NRF2, InhaTarget’s proprietary formulation platform and strong experience in pulmonary drug development, and Merxin Ltd’s advanced inhalation device technology. Through their combined expertise, they aim to create a patient-friendly inhaled therapy that delivers targeted treatment directly to lung tumors, maximizing efficacy, minimizing systemic side effects, and offering new hope for patients facing one of the world’s deadliest cancers. Innovativ
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies2.12.2025 14:00:00 CET | Press release
Aurigene Oncology Limited, a clinical-stage biopharmaceutical company developing novel therapies in oncology,today announced initial clinical results from 1st two cohorts of its ongoing Phase 1 clinical trial evaluating AUR112 in patients with relapsed or refractory lymphoid malignancies. Early findings show that AUR112 is safe, well tolerated, demonstrating meaningful clinical activity, with objective responses observed across multiple lymphoma subtypes, including Mantle Cell Lymphoma (MCL) and Marginal Zone Lymphoma (MZL). “We are very encouraged by the early results of the first two cohorts from our Phase 1 study of AUR112,” said Dr. Murali Ramachandra, CEO. “AUR112 has shown a promising initial clinical profile, achieving an overall response rate of 63.6% in the efficacy-evaluable population and 58.3% in the intent-to-treat group. These strong early data, combined with its distinct preclinical and safety characteristics, reinforce our belief that AUR112 has the potential to become
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer2.12.2025 14:00:00 CET | Press release
Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025 The Phase 2 expansion will evaluate 160 MBq and 200 MBq doses of ADVC001 using a randomized, multi-dose-response design and adaptive dosing strategies to optimize clinical outcomes across three indications: metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC) in pre-chemotherapy and post-177Lu-PSMA radioligand therapy (RLT) settings AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the initiation of the TheraPb Phase 2 expansion trial (NCT05720130) evaluating its lead investigational candidate, ADVC001, in metastatic prostate cancer. The news follows the encouraging Phase 1b dose escalation results presented at the European Society for Medical Oncology (ESMO) 2025 congress that showed a favorable safety profile and compelling
Luma AI Opens for International Business With Former WPP Executive Jason Day Leading New London Office2.12.2025 14:00:00 CET | Press release
Establishment of the London office follows Luma AI’s $900 million Series C investment led by HUMAIN - marking the company’s first major step towards international scale with plans to deepen partnerships across the UK, European Union, and Saudi Arabia in the first phase of expansion.Former Monks and WPP executive Jason Day was appointed Head of EMEA to launch Luma AI internationally and drive worldwide growth across creative, advertising, gaming, and entertainment sectors.Luma AI plans to add 200 new jobs in London in 2026. Luma AI, the frontier artificial intelligence company building multimodal AGI intelligence and known for its flagship product Dream Machine, today announced a major step in its global expansion with the opening of its first international office in London, UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202217704/en/ LUMA AI OPENS FOR INTERNATIONAL BUSINESS WITH FORMER WPP EXECUTIVE JASON DAY LEADING
Eventbrite Enters into Definitive Agreement to Be Acquired by Bending Spoons for Roughly $500 Million to Accelerate Eventbrite’s Next Phase of Growth2.12.2025 13:30:00 CET | Press release
Eventbrite stockholders to receive $4.50 per share in cash Eventbrite, Inc. (NYSE: EB), the leading global marketplace for shared experiences, announced today that it has entered into a definitive agreement to be acquired by Bending Spoons, in an all-cash transaction valued at approximately $500 million. The acquisition is subject to customary closing conditions and approvals, including regulatory approvals and approval by Eventbrite’s stockholders. “For two decades, Eventbrite has stood at the forefront of the experience economy, helping tens of millions to create, discover, and attend unforgettable events,” said Luca Ferrari, Bending Spoons CEO and Co-Founder. “Joining forces with Bending Spoons will accelerate innovation and strengthen Eventbrite’s tools and resources to bring even more people together through shared live experiences for many years to come. As longstanding fans, we’ve identified a few opportunities that we’re excited about exploring with the Eventbrite team after cl
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom